Usefulness of vasodilator therapy in acute and chronic valvular regurgitation.
D001021:Aortic Valve / Q000503:physiopathology; D001022:Aortic Valve Insufficiency / Q000188:drug therapy* / Q000503:physiopathology; D003131:Combined Modality Therapy; D004077:Digoxin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006333:Heart Failure / Q000188:drug therapy; D006350:Heart Valve Prosthesis; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D008943:Mitral Valve / Q000503:physiopathology; D008944:Mitral Valve Insufficiency / Q000188:drug therapy* / Q000503:physiopathology; D009599:Nitroprusside / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D014665:Vasodilator Agents; D009599:Nitroprusside; D006830:Hydralazine; D004077:Digoxin